12 research outputs found
Recommended from our members
Impact of distributed energy resources on the reliability of a critical telecommunications facility.
This report documents a probabilistic risk assessment of an existing power supply system at a large telecommunications office. The focus is on characterizing the increase in the reliability of power supply through the use of two alternative power configurations. Telecommunications has been identified by the Department of Homeland Security as a critical infrastructure to the United States. Failures in the power systems supporting major telecommunications service nodes are a main contributor to major telecommunications outages. A logical approach to improve the robustness of telecommunication facilities would be to increase the depth and breadth of technologies available to restore power in the face of power outages. Distributed energy resources such as fuel cells and gas turbines could provide one more onsite electric power source to provide backup power, if batteries and diesel generators fail. The analysis is based on a hierarchical Bayesian approach and focuses on the failure probability associated with each of three possible facility configurations, along with assessment of the uncertainty or confidence level in the probability of failure. A risk-based characterization of final best configuration is presented
A Selective HDAC 1/2 Inhibitor Modulates Chromatin and Gene Expression in Brain and Alters Mouse Behavior in Two Mood-Related Tests
Psychiatric diseases, including schizophrenia, bipolar disorder and major depression, are projected to lead global disease burden within the next decade. Pharmacotherapy, the primary – albeit often ineffective – treatment method, has remained largely unchanged over the past 50 years, highlighting the need for novel target discovery and improved mechanism-based treatments. Here, we examined in wild type mice the impact of chronic, systemic treatment with Compound 60 (Cpd-60), a slow-binding, benzamide-based inhibitor of the class I histone deacetylase (HDAC) family members, HDAC1 and HDAC2, in mood-related behavioral assays responsive to clinically effective drugs. Cpd-60 treatment for one week was associated with attenuated locomotor activity following acute amphetamine challenge. Further, treated mice demonstrated decreased immobility in the forced swim test. These changes are consistent with established effects of clinical mood stabilizers and antidepressants, respectively. Whole-genome expression profiling of specific brain regions (prefrontal cortex, nucleus accumbens, hippocampus) from mice treated with Cpd-60 identified gene expression changes, including a small subset of transcripts that significantly overlapped those previously reported in lithium-treated mice. HDAC inhibition in brain was confirmed by increased histone acetylation both globally and, using chromatin immunoprecipitation, at the promoter regions of upregulated transcripts, a finding consistent with in vivo engagement of HDAC targets. In contrast, treatment with suberoylanilide hydroxamic acid (SAHA), a non-selective fast-binding, hydroxamic acid HDAC 1/2/3/6 inhibitor, was sufficient to increase histone acetylation in brain, but did not alter mood-related behaviors and had dissimilar transcriptional regulatory effects compared to Cpd-60. These results provide evidence that selective inhibition of HDAC1 and HDAC2 in brain may provide an epigenetic-based target for developing improved treatments for mood disorders and other brain disorders with altered chromatin-mediated neuroplasticity.Stanley Medical Research InstituteNational Institutes of Health (U.S.) (R01DA028301)National Institutes of Health (U.S.) (R01DA030321
Recommended from our members
Net-zero emissions energy systems
Some energy services and industrial processes-such as long-distance freight transport, air travel, highly reliable electricity, and steel and cement manufacturing-are particularly difficult to provide without adding carbon dioxide (CO
) to the atmosphere. Rapidly growing demand for these services, combined with long lead times for technology development and long lifetimes of energy infrastructure, make decarbonization of these services both essential and urgent. We examine barriers and opportunities associated with these difficult-to-decarbonize services and processes, including possible technological solutions and research and development priorities. A range of existing technologies could meet future demands for these services and processes without net addition of CO
to the atmosphere, but their use may depend on a combination of cost reductions via research and innovation, as well as coordinated deployment and integration of operations across currently discrete energy industries
Sodium Butyrate Prevents Memory Impairment by Re-establishing BDNF and GDNF Expression in Experimental Pneumococcal Meningitis
Histone deacetylase activity and brain-derived neurotrophic factor (BDNF) levels in a pharmacological model of mania
N-acetyl cysteine reverses social isolation rearing induced changes in cortico-striatal monoamines in rats
Schizophrenia is causally associated with early-life
environmental stress, implicating oxidative stress in its pathophysiology.
N-acetyl cysteine (NAC), a glutathione precursor
and antioxidant, is emerging as a useful agent in the adjunctive
treatment of schizophrenia and other psychiatric illnesses.
However, its actions on brain monoamine metabolism are
unknown. Social isolation rearing (SIR) in rats presents with
face, predictive and construct validity for schizophrenia. This
study evaluated the dose-dependent effects of NAC (50, 150
and 250 mg/kg/day × 14 days) on SIR- vs. socially reared
induced changes in cortico-striatal levels of dopamine (DA),
serotonin (5-HT) noradrenaline (NA) and their associated metabolites.
SIR induced significant deficits in frontal corticalDA
and its metabolites, 3,4-dihydroxyphenylacetic acid (Dopac)
and homovanillic acid (HVA), reduced 5-HT and its metabolite,
5-hydroxyindoleacetic acid (5-HIAA), and reduced levels
of the NA metabolite, 3-methoxy-4-hydroxyphenylglycol
(MHPG). In addition, significant elevations in frontal cortical
NA and striatal DA, Dopac, HVA, 5-HT, 5-HIAA, NA and
MHPG were also observed in SIR rats. NAC at 150 and
250 mg/kg reversed all cortico-striatal DA, Dopac, HVA, 5-
HT, 5-HIAA and striatal NA alterations in SIR animals, with
250 mg/kg of NAC also reversing alterations in cortico-striatal
MHPG. In conclusion, SIR profoundly alters cortico-striatal
DA, 5-HT and NA pathways that parallel observations in
schizophrenia, while these changes are dose-dependently reversed
or abrogated by sub-chronic NAC treatment. A modulatory
action on cortico-striatal monoamines may explain
NACs’ therapeutic use in schizophrenia and possibly other
psychiatric disorders, where redox dysfunction or oxidative
stress is a causal factor